Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hepatic Impairment × capmatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 3 cMET-dysregulated Advanced Solid Tumors 2 Neoplasm Metastasis 2 Melanoma 2 Glioblastoma 2 Adenocarcinoma of Lung 2 Malignant Non-small Cell Neoplasm of Lung Stage IV 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hepatic Impairment 1 Gliosarcoma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Bronchial Neoplasms 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02474537 2020-12-10

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Novartis

Phase 1 Completed

Hepatic Impairment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡